91 related articles for article (PubMed ID: 8315222)
1. The effect of improved glycemic control on cognitive functions in the elderly patient with diabetes.
Meneilly GS; Cheung E; Tessier D; Yakura C; Tuokko H
J Gerontol; 1993 Jul; 48(4):M117-21. PubMed ID: 8315222
[TBL] [Abstract][Full Text] [Related]
2. Verbal learning and/or memory improves with glycemic control in older subjects with non-insulin-dependent diabetes mellitus.
Gradman TJ; Laws A; Thompson LW; Reaven GM
J Am Geriatr Soc; 1993 Dec; 41(12):1305-12. PubMed ID: 8227912
[TBL] [Abstract][Full Text] [Related]
3. Short-term effects of improved glycemic control on cognitive function in patients with type 2 diabetes.
Hewer W; Mussell M; Rist F; Kulzer B; Bergis K
Gerontology; 2003; 49(2):86-92. PubMed ID: 12574669
[TBL] [Abstract][Full Text] [Related]
4. Insulin binding in non-insulin-dependent diabetes mellitus (NIDDM) is correlated with glycemic control: clinical evidence for abnormal receptor regulation in NIDDM.
Kelly CM; Fantus IG
Metabolism; 1995 Apr; 44(4):506-12. PubMed ID: 7723674
[TBL] [Abstract][Full Text] [Related]
5. Optimization of glycemic control by insulin therapy decreases the proportion of small dense LDL particles in diabetic patients.
Caixàs A; Ordóñez-Llanos J; de Leiva A; Payés A; Homs R; Pérez A
Diabetes; 1997 Jul; 46(7):1207-13. PubMed ID: 9200657
[TBL] [Abstract][Full Text] [Related]
6. Cognitive function in patients with insulin-dependent diabetes mellitus during hyperglycemia and hypoglycemia.
Draelos MT; Jacobson AM; Weinger K; Widom B; Ryan CM; Finkelstein DM; Simonson DC
Am J Med; 1995 Feb; 98(2):135-44. PubMed ID: 7847430
[TBL] [Abstract][Full Text] [Related]
7. Effect of type II diabetes mellitus on cognitive function.
Worrall G; Moulton N; Briffett E
J Fam Pract; 1993 Jun; 36(6):639-43. PubMed ID: 8505607
[TBL] [Abstract][Full Text] [Related]
8. Effect of conventional and intensified insulin therapy on free-insulin profiles and glycemic control in NIDDM.
Lindström TH; Arnqvist HJ; von Schenck HH
Diabetes Care; 1992 Jan; 15(1):27-34. PubMed ID: 1737539
[TBL] [Abstract][Full Text] [Related]
9. Low-glycemic index foods improve long-term glycemic control in NIDDM.
Brand JC; Colagiuri S; Crossman S; Allen A; Roberts DC; Truswell AS
Diabetes Care; 1991 Feb; 14(2):95-101. PubMed ID: 2060429
[TBL] [Abstract][Full Text] [Related]
10. Plasma 1,5-anhydro-D-glucitol as new clinical marker of glycemic control in NIDDM patients.
Yamanouchi T; Minoda S; Yabuuchi M; Akanuma Y; Akanuma H; Miyashita H; Akaoka I
Diabetes; 1989 Jun; 38(6):723-9. PubMed ID: 2656341
[TBL] [Abstract][Full Text] [Related]
11. The Fasting Hyperglycaemia Study: III. Randomized controlled trial of sulfonylurea therapy in subjects with increased but not diabetic fasting plasma glucose.
Karunakaran S; Hammersley MS; Morris RJ; Turner RC; Holman RR
Metabolism; 1997 Dec; 46(12 Suppl 1):56-60. PubMed ID: 9439561
[TBL] [Abstract][Full Text] [Related]
12. Combined metformin-sulfonylurea treatment of patients with noninsulin-dependent diabetes in fair to poor glycemic control.
Reaven GM; Johnston P; Hollenbeck CB; Skowronski R; Zhang JC; Goldfine ID; Chen YD
J Clin Endocrinol Metab; 1992 May; 74(5):1020-6. PubMed ID: 1569149
[TBL] [Abstract][Full Text] [Related]
13. Type-2 diabetes and cognitive function in a non-demented population.
Vanhanen M; Kuusisto J; Koivisto K; Mykkänen L; Helkala EL; Hänninen T; Riekkinen P; Soininen H; Laakso M
Acta Neurol Scand; 1999 Aug; 100(2):97-101. PubMed ID: 10442450
[TBL] [Abstract][Full Text] [Related]
14. Humalog Mix 25 in patients with type 2 diabetes which do not achieve acceptable glycemic control with oral agents: results from a phase III, randomized, parallel study.
Tîrgovişte CI; Străchinariu R; Farcaşiu E; Milicevic Z; Teodorescu G
Rom J Intern Med; 2003; 41(2):153-62. PubMed ID: 15526500
[TBL] [Abstract][Full Text] [Related]
15. Differential effects of human and animal insulin on the responses to hypoglycemia in elderly patients with NIDDM.
Meneilly GS; Milberg WP; Tuokko H
Diabetes; 1995 Mar; 44(3):272-7. PubMed ID: 7883113
[TBL] [Abstract][Full Text] [Related]
16. Risk for non-insulin-dependent diabetes in the normoglycaemic elderly is associated with impaired cognitive function.
Vanhanen M; Koivisto K; Karjalainen L; Helkala EL; Laakso M; Soininen H; Riekkinen P
Neuroreport; 1997 Apr; 8(6):1527-30. PubMed ID: 9172168
[TBL] [Abstract][Full Text] [Related]
17. Long-term effects of a sustained-release preparation of acipimox on dyslipidemia and glucose metabolism in non-insulin-dependent diabetes mellitus.
Davoren PM; Kelly W; Gries FA; Hubinger A; Whately-Smith C; Alberti KG
Metabolism; 1998 Mar; 47(3):250-6. PubMed ID: 9500558
[TBL] [Abstract][Full Text] [Related]
18. Management of newly diagnosed non-insulin-dependent diabetes mellitus in the primary care setting: effects of 2 years of gliclazide treatment--the Diadem Study.
Cathelineau G; de Champvallins M; Bouallouche A; Lesobre B
Metabolism; 1997 Dec; 46(12 Suppl 1):31-4. PubMed ID: 9439556
[TBL] [Abstract][Full Text] [Related]
19. Differential impact of cerebral white matter changes, diabetes, hypertension and stroke on cognitive performance among non-disabled elderly. The LADIS study.
Verdelho A; Madureira S; Ferro JM; Basile AM; Chabriat H; Erkinjuntti T; Fazekas F; Hennerici M; O'Brien J; Pantoni L; Salvadori E; Scheltens P; Visser MC; Wahlund LO; Waldemar G; Wallin A; Inzitari D;
J Neurol Neurosurg Psychiatry; 2007 Dec; 78(12):1325-30. PubMed ID: 17470472
[TBL] [Abstract][Full Text] [Related]
20. Impact of associated conditions on glycemic control of NIDDM patients.
Ferrannini E; Stern MP; Galvan AQ; Mitchell BD; Haffner SM
Diabetes Care; 1992 Apr; 15(4):508-14. PubMed ID: 1499466
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
